Today: Dec 22, 2024
RU / EN
Last update: Oct 30, 2024
Home page → All issues → Volume 15, Issue 5 (2023) → Article details
Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base: Evaluation of the Effectiveness of Treatment Methods (Review)

Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base: Evaluation of the Effectiveness of Treatment Methods (Review)

Lemaeva A.A., Gulidov I.A.
Key words: chordoma; chondrosarcoma; skull base; radiation therapy; proton therapy.
2023, volume 15, issue 5, page 44.
DOI: https://doi.org/10.17691/stm2023.15.5.05

Full text

html pdf
598
777

Chordomas and chondrosarcomas of the skull base are rare tumors. They are located in close proximity to critical structures, which poses a serious problem in the treatment of these tumors. Despite advances in surgery, radical resection is often not possible. Radiation therapy for chordomas and chondrosarcomas of the skull base is able to improve overall survival and local control.

The aim of this review is to analyze the literature data and evaluate the efficacy of radiation therapy techniques for chordomas and chondrosarcomas of the skull base. The most promising methods of radiation therapy for chordomas and chondrosarcomas of the skull base have been shown to be pencil-beam scanning proton therapy with intensity modulation and carbon ion therapy. These techniques have demonstrated high local control and overall survival with a low incidence of severe radiation-induced toxicity, which confirms their clinical benefits. It has also been found that stereotactic radiosurgery can be effectively used for small tumors (less than 7 cm3).

  1. Mizerny B.R., Kost K.M. Chordoma of the cranial base: the McGill experience. J Otolaryngol 1995; 24(1): 14–19.
  2. Lee S.Y., Lim Y.C., Song M.H., Seok J.Y., Lee W.S., Choi E.C. Chondrosarcoma of the head and neck. Yonsei Med J 2005; 46(2): 228–232, https://doi.org/10.3349/ymj.2005.46.2.228.
  3. Cianfriglia F., Pompili A., Occhipinti E. Intracranial malignant cartilaginous tumours. Report of two cases and review of literature. Acta Neurochir (Wien) 1978; 45(1-2): 163–175, https://doi.org/10.1007/bf01774391.
  4. Wedekind M.F., Widemann B.C., Cote G. Chordoma: current status, problems, and future directions. Curr Probl Cancer 2021; 45(4): 100771, https://doi.org/10.1016/j.currproblcancer.2021.100771.
  5. Scheipl S., Igrec J., Leithner A., Smolle M., Haybäck J., Liegl B. Chordoma: is there a molecular basis for diagnosis and treatment? Pathologe 2020; 41(2): 153–162, https://doi.org/10.1007/s00292-020-00761-4.
  6. Tenny S., Varacallo M. Chordoma. Treasure Island (FL): StatPearls Publishing; 2022.
  7. Radiopaedia. Chondrosarcoma of the skull base. URL: https://radiopaedia.org/articles/chondrosarcoma-of-the-skull-base?lang=us.
  8. Chambers K.J., Lin D.T., Meier J., Remenschneider A., Herr M., Gray S.T. Incidence and survival patterns of cranial chordoma in the United States. Laryngoscope 2014; 124(5): 1097–1102, https://doi.org/10.1002/lary.24420.
  9. Walcott B.P., Nahed B.V., Mohyeldin A., Coumans J.V., Kahle K.T., Ferreira M.J. Chordoma: current concepts, management, and future directions. Lancet Oncol 2012; 13(2): e69–e76, https://doi.org/10.1016/s1470-2045(11)70337-0.
  10. Kremenevski N., Schlafer S.M., Coras R., Kinfe T.M., Graillon T., Buchfelder M. Skull base chordomas and chondrosarcomas. Neuroendocrinology 2020; 110(9–10): 836–847, https://doi.org/10.1159/000509386.
  11. Arnautović K.I., Al-Mefty O. Surgical seeding of chordomas. Neurosurg Focus 2001; 10(3): E7.
  12. Roberti F., Sekhar L.N., Jones R.V., Wright D.C. Intradural cranial chordoma: a rare presentation of an uncommon tumor. Surgical experience and review of the literature. J Neurosurg 2007; 106(2): 270–274, https://doi.org/10.3171/jns.2007.106.2.270.
  13. Lustig L.R., Sciubba J., Holliday M.J. Chondrosarcomas of the skull base and temporal bone. J Laryngol Otol 2007; 121(8): 725–735, https://doi.org/10.1017/s0022215107006081.
  14. Igaki H., Tokuuye K., Okumura T., Sugahara S., Kagei K., Hata M., Ohara K., Hashimoto T., Tsuboi K., Takano S., Matsumura A., Akine Y. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 2004; 60(4): 1120–1126, https://doi.org/10.1016/j.ijrobp.2004.05.064.
  15. Italiano A., Mir O., Cioffi A., Palmerini E., Piperno-Neumann S., Perrin C., Chaigneau L., Penel N., Duffaud F., Kurtz J.E., Collard O., Bertucci F., Bompas E., Le Cesne A., Maki R.G., Ray Coquard I., Blay J.Y. Advanced chondrosarcomas: role of chemotherapy and survival. Ann Oncol 2013; 24(11): 2916–2922, https://doi.org/10.1093/annonc/mdt374.
  16. Diaz R.J., Cusimano M.D. The biological basis for modern treatment of chordoma. J Neurooncol 2011; 104(2): 411–422, https://doi.org/10.1007/s11060-011-0559-8.
  17. Al-Mefty O., Borba L.A. Skull base chordomas: a management challenge. J Neurosurg 1997; 86(2): 182–189, https://doi.org/10.3171/jns.1997.86.2.0182.
  18. Tzortzidis F., Elahi F., Wright D., Natarajan S.K., Sekhar L.N. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 2006; 59(2): 230–237, https://doi.org/10.1227/01.neu.0000223441.51012.9d.
  19. Feuvret L., Bracci S., Calugaru V., Bolle S., Mammar H., De Marzi L., Bresson D., Habrand J.L., Mazeron J.J., Dendale R., Noël G. Efficacy and safety of adjuvant proton therapy combined with surgery for chondrosarcoma of the skull base: a retrospective, population-based study. Int J Radiat Oncol Biol Phys 2016; 95(1): 312–321, https://doi.org/10.1016/j.ijrobp.2015.12.016.
  20. Gay E., Sekhar L.N., Rubinstein E., Wright D.C., Sen C., Janecka I.P., Snyderman C.H. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995; 36(5): 887–896, https://doi.org/10.1097/00006123-199505000-00001.
  21. Schulz-Ertner D., Karger C.P., Feuerhake A., Nikoghosyan A., Combs A.E., Jäkel O., Edler L., Scholz M., Debus J. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007; 68(2): 449–457, https://doi.org/10.1016/j.ijrobp.2006.12.059.
  22. Bloch O.G., Jian B.J., Yang I., Han S.J., Aranda D., Ahn B.J., Parsa A.T. A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci 2009; 16(12): 1547–1551, https://doi.org/10.1016/j.jocn.2009.05.003.
  23. Fossati P., Vavassori A., Deantonio L., Ferrara E., Krengli M., Orecchia R. Review of photon and proton radiotherapy for skull base tumours. Rep Pract Oncol Radiother 2016; 21(4): 336–355, https://doi.org/10.1016/j.rpor.2016.03.007.
  24. Martin J.J., Niranjan A., Kondziolka D., Flickinger J.C., Lozanne K.A., Lunsford L.D. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg 2007; 107(4): 758–764, https://doi.org/10.3171/jns-07/10/0758.
  25. Krishnan S., Foote R.L., Brown P.D., Pollock B.E., Link M.J., Garces Y.I. Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery 2005; 56(4): 777–784, https://doi.org/10.1227/01.neu.0000156789.10394.f5.
  26. Hasegawa T., Ishii D., Kida Y., Yoshimoto M., Koike J., Iizuka H. Gamma knife surgery for skull base chordomas and chondrosarcomas. J Neurosurg 2007; 107(4): 752–757, https://doi.org/10.3171/jns-07/10/0752.
  27. Cahill J., Ibrahim R., Mezey G., Yianni J., Bhattacharyya D., Walton L., Grainger A., Radatz M.W.R. Gamma knife stereotactic radiosurgery for the treatment of chordomas and chondrosarcomas. Acta Neurochir (Wien) 2021; 163(4): 1003–1011, https://doi.org/10.1007/s00701-021-04768-5.
  28. Palm R.F., Oliver D.E., Yang G.Q., Abuodeh Y., Naghavi A.O., Johnstone P.A.S. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the National Cancer Data Base. Cancer 2019; 125(4): 642–651, https://doi.org/10.1002/cncr.31958.
  29. Proton and charged particle radiotherapy. Delaney T.F., Kooy H.M. (editors). Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
  30. Terapevticheskaya radiologiya: natsional’noe rukovodstvo [Therapeutic radiology: national guidelines]. Kaprin A.D., Mardynskiy Yu.S. (editors). Moscow: GEOTAR-Media; 2018; p. 46–47.
  31. Gordon K.B., Smyk D.I., Gulidov I.А. Proton therapy in head and neck cancer treatment: state of the problem and development prospects (review). Sovremennye tehnologii v medicine 2021; 13(4): 70, https://doi.org/10.17691/stm2021.13.4.08.
  32. Liu H., Chang J.Y. Proton therapy in clinical practice. Chin J Cancer 2011; 30(5): 315–326, https://doi.org/10.5732/cjc.010.10529.
  33. Kanai T., Kawachi K., Kumamoto Y., Ogawa H., Yamada T., Matsuzawa H., Inada T. Spot scanning system for proton radiotherapy. Med Phys 1980; 7(4): 365–369, https://doi.org/10.1118/1.594693.
  34. Pedroni E., Bacher R., Blattmann H., Böhringer T., Coray A., Lomax A., Lin S., Munkel G., Scheib S., Schneider U., Tourovsky A. The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. Med Phys 1995; 22(1): 37–53, https://doi.org/10.1118/1.597522.
  35. Lomax A. Intensity modulation methods for proton therapy. Phys Med Biol 1999; 44: 185–205, https://doi.org/10.1088/0031-9155/44/1/014.
  36. Lomax A.J., Boehringer T., Coray A., Egger E., Goitein G., Grossmann M., Juelke P., Lin S., Pedroni E., Rohrer B., Roser W., Rossi B., Siegenthaler B., Stadelmann O., Stauble H., Vetter C., Wisser L. Intensity modulated proton therapy: a clinical example. Med Phys 2001; 28(3): 317–324, https://doi.org/10.1007/978-3-642-59758-9_121.
  37. Lomax A.J., Pedroni E., Rutz H.P., Goitein G. The clinical potential of intensity modulated proton therapy. Z Med Phys 2004; 14(3): 147–152, https://doi.org/10.1078/0939-3889-00217.
  38. Particle Therapy Co-Operative Group. Particle therapy facilities in clinical operation (last update: august 2023). Information about technical equipment. URL: https://www.ptcog.site/index.php/facilities-in-operation-public.
  39. Kosaki K., Ecker S., Habermehl D., Rieken S., Jäkel O., Herfarth K., Debus J., Combs S.E. Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas. Radiat Oncol 2012; 7: 44, https://doi.org/10.1186/1748-717x-7-44.
  40. Munzenrider J.E., Liebsch N.J. Proton therapy for tumors of the skull base. Strahlether Onkol 1999; 175(S2): 57–63, https://doi.org/10.1007/bf03038890.
  41. Hug E.B., Loredo L.N., Slater J.D., DeVries A., Grove R.I., Schaefer R.A., Rosenberg A.E., Slater J.M. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999; 91(3): 432–439, https://doi.org/10.3171/jns.1999.91.3.0432.
  42. Ares C., Hug E.B., Lomax A.J., Bolsi A., Timmermann B., Rutz H.P., Schuller J.C., Pedroni E., Goitein G. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys 2009; 75(4): 1111–1118, https://doi.org/10.1016/j.ijrobp.2008.12.055.
  43. Parzen J.S., Li X., Zheng W., Ding X., Kabolizadeh P. Proton therapy for skull-base chordomas and chondrosarcomas: initial results from the Beaumont Proton Therapy Center. Cureus 2021; 13(5): e15278, https://doi.org/10.7759/cureus.15278.
  44. Holtzman A.L., Rotondo R.L., Rutenberg M.S., Indelicato D.J., De Leo A., Rao D., Patel J., Morris C.G., Mendenhall W.M. Clinical outcomes following dose-escalated proton therapy for skull-base chordoma. Int J Part Ther 2021; 8(1): 179–188, https://doi.org/10.14338/ijpt-20-00066.1.
  45. Gordon K., Gulidov I., Koryakin S., Smyk D., Makeenkova T., Gogolin D., Lepilina O., Golovanova O., Semenov A., Dujenko S., Medvedeva K., Mardynsky Y. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity. Radiat Oncol 2021; 16(1): 238, https://doi.org/10.1186/s13014-021-01961-9.
  46. Grosshans D.R., Zhu X.R., Melancon A., Allen P.K., Poenisch F., Palmer M., McAleer M.F., McGovern S.L., Gillin M., DeMonte F., Chang E.L., Brown P.D., Mahajan A. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. Int J Radiat Oncol Biol Phys 2014; 90(3): 540–546, https://doi.org/10.1016/j.ijrobp.2014.07.005.
  47. Nie M., Chen L., Zhang J., Qiu X. Pure proton therapy for skull base chordomas and chondrosarcomas: a systematic review of clinical experience. Front Oncol 2022; 12: 1016857, https://doi.org/10.3389/fonc.2022.1016857.
  48. Mizoe J., Hasegawa A., Takagi R., Bessho H., Onda T., Tsujii H. Carbon ion radiotherapy for skull base chordoma. Skull Base 2009; 19(3): 219–224, https://doi.org/10.1055/s-0028-1114295.
  49. Uhl M., Mattke M., Welzel T., Roeder F., Oelmann J., Habl G., Jensen A., Ellerbrock M., Jäkel O., Haberer T., Herfarth K., Debus J. Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results. Cancer 2014; 120(21): 3410–3417, https://doi.org/10.1002/cncr.28877.
  50. Guan X., Gao J., Hu J., Hu W., Yang J., Qiu X., Hu C., Kong L., Lu J.J. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine. Radiat Oncol 2019; 14(1): 206, https://doi.org/10.1186/s13014-019-1407-9.
  51. Mattke M., Ohlinger M., Bougatf N., Harrabi S., Wolf R., Seidensaal K., Welzel T., Röder F., Gerum S., Ellerbrock M., Jäkel O., Haberer T., Herfarth K., Uhl M., Debus J. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center — a single-center experience. Strahlenther Onkol 2022; 1999(2): 160–168, https://doi.org/10.1007/s00066-022-02002-4.
  52. Iannalfi A., D’Ippolito E., Riva G., Molinelli S., Gandini S., Viselner G., Fiore M.R., Vischioni B., Vitolo V., Bonora M., Ronchi S., Petrucci R., Barcellini A., Mirandola A., Russo S., Vai A., Mastella E., Magro G., Maestri D., Ciocca M., Preda L., Valvo F., Orecchia R. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy. Neuro Oncol 2020; 22(9): 1348–1358, https://doi.org/10.1093/neuonc/noaa067.
  53. National Comprehensive Cancer Network. Bone cancer (version 1.2022). URL: https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf.
  54. Casali P.G., Bielack S., Abecassis N., Aro H.T., Bauer S., Biagini R., Bonvalot S., Boukovinas I., Bovee J.V.M.G., Brennan B., Brodowicz T., Broto J.M., Brugières L., Buonadonna A., De Álava E., Dei Tos A.P., Del Muro X.G., Dileo P., Dhooge C., Eriksson M., Fagioli F., Fedenko A., Ferraresi V., Ferrari A., Ferrari S., Frezza A.M., Gaspar N., Gasperoni S., Gelderblom H., Gil T., Grignani G., Gronchi A., Haas R.L., Hassan B., Hecker-Nolting S., Hohenberger P., Issels R., Joensuu H., Jones R.L., Judson I., Jutte P., Kaal S., Kager L., Kasper B., Kopeckova K., Krákorová D.A., Ladenstein R., Le Cesne A., Lugowska I., Merimsky O., Montemurro M., Morland B., Pantaleo M.A., Piana R., Picci P., Piperno-Neumann S., Pousa A.L., Reichardt P., Robinson M.H., Rutkowski P., Safwat A.A., Schöffski P., Sleijfer S., Stacchiotti S., Strauss S.J., Sundby Hall K., Unk M., Van Coevorden F., van der Graaf W.T.A., Whelan J., Wardelmann E., Zaikova O., Blay J.Y.; ESMO Guidelines Committee, PaedCan and ERN EURACAN. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29(Suppl 4): IV79–IV95, https://doi.org/10.1093/annonc/mdy310.
Lemaeva A.A., Gulidov I.A. Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base: Evaluation of the Effectiveness of Treatment Methods (Review). Sovremennye tehnologii v medicine 2023; 15(5): 44, https://doi.org/10.17691/stm2023.15.5.05


Journal in Databases

pubmed_logo.jpg

web_of_science.jpg

scopus.jpg

crossref.jpg

ebsco.jpg

embase.jpg

ulrich.jpg

cyberleninka.jpg

e-library.jpg

lan.jpg

ajd.jpg

SCImago Journal & Country Rank

Publication is registered by Federal Service for Supervision in the Sphere of Telecom, Information Technologies and Mass Communications.
Mass Media Registration Certificate PE № FS 77-79187 dated October 16, 2020.

If reproducing any part of the publication a reference to the Journal is obligatory.